In the study by Wen et al., a DNA-based vaccine targeting fibroblast activation protein (FAP) in CAFs was designed to immunize model mice of colon cancer, resulting in the decreased expression of FAP+CAF and collagen fibers in the tumor stroma, thereby leading to an increase in T lymphocyte infiltration. The gene discussed is FAP; the disease is malignant colon neoplasm.